Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Summary

RATIONALE: Vaccines made from a person's white blood cells mixed with peptides may make the body build an immune response to kill cancer cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with refractory stage IV cancer.

Timeline

Start

2003-09

Primary completion

2006-08

Completion

2006-09

Drugs

Indications